Mini-Focus Issue: Congenital Heart DiseaseClinical ResearchPregnant Women With Uncorrected Congenital Heart Disease: Heart Failure and Mortality
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Since the start of the European Society of Cardiology EORP ROPAC program, the following companies have supported the programme: Abbott Vascular International (2011-2021), Amgen Cardiovascular (2009-2018), AstraZeneca (2014-2021), Bayer AG (2009-2018), Boehringer Ingelheim (2009-2019), Boston Scientific (2009-2012), Bristol-Myers Squibb and Pfizer Alliance (2011-2019), Daiichi Sankyo Europe GmbH (2011-2020), Daiichi Sankyo Europe GmbH and Eli Lilly and Company Alliance (2014-2017), Edwards (2016-2019), Gedeon Richter Plc. (2014-2016), Menarini Int. Op. (2009-2012), MSD-Merck & Co. (2011-2014), Novartis Pharma AG (2014-2020), ResMed (2014-2016), Sanofi (2009-2011), and Servier (2009-2012). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.